Friday June 16 2017 at 12-13.30 pm CET
@ Cellectricon head office Mölndal, Sweden

Join our free seminar to learn about:

  • Cellectricon’s unique technology platform and discovery services.
  • Phenotypic screening approaches in pain research and how iPSC-derived neurons can be used in drug discovery.
  • Principles of our humanized phenotypic screening platform and how it can be applied for stem cell-based screening against disease-relevant phenotypes.

Registration for this event is now closed. Contact us to learn more.


 12:00 – Pick up at Hotel Gothia Towers main reception and transport to Cellectricon head office.

 12:15 – Brief company introduction and overview presentation of Cellaxess Elektra platform. 
  Presenter: Dr Mattias Karlsson, CEO Cellectricon AB

 12:25 – Lab tour including detailed walk through of Cellaxess Elektra platform. 
  Presenter: Dr Johan Pihl, VP Technology and Engineering

 12:50 – Case study presentation “A humanized screening platform targeting chronic pain”. 
  Presenter: Dr Paul Karila, VP Discovery Services

 13:20 – Return transport to NeuPSIG (6th International Congress on Neuropathic Pain) conference venue.

The event is free to attend and lunch will be provided. Spaces are limited, please register your interest and the organisers will be in touch.